Skip to main content

Table 1 Mutation information in A. baumannii SMGC-AB2 isolated from H7N9 patient B4a

From: Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study

No.

Gene Annotation

ORF length

position (NT)

mutation (NT)

AA length

position (AA)

substitute (AA)

1

putative permease, YjgP/YjgQ family protein

1101 bp

164

G → A

366

55

Arg → His

2

histidine kinase; PmrB

1335

704

C → T

444

235

Thr → Ile

3

Lipid A phosphoethanolamine transferase, associated with polymyxin resistance, PmrC

1647

1598

A → C

548

533

Lys → Thr

4

NAD-dependent aldehyde dehydrogenase

1575

421

C → T

524

141

Leu → Leu

5

Large repetitive protein, type I secretion C-terminal target domain protein

6657

547

A → G

2218

183

Val → Ile

6

Large repetitive protein, type I secretion C-terminal target domain protein

6657

874

G → A

2218

292

Val → Ile

7

Large repetitive protein, type I secretion C-terminal target domain protein

6657

876

T → C

2218

292

Val → Ile

8

Contig C497

8383 (position)

C → T

Non-coding region

  1. aThe reference sequence is A. baumannii SMGC-AB1 isolated from H7N9 patient B4 isolated on Day 21 after disease onset. A. baumannii SMGC-AB2 was isolated from this patient B4 on Day 26 after disease onset